Capricor Therapeutics Announces Closing Of Underwritten Public Offering And Full Exercise Of The Underwriters’ Option To Purchase Additional Shares

(MENAFN - GlobeNewsWire - Nasdaq) SAN DIEGO, Oct. 18, 2024 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based ...Ads Links by Easy Branches
Play online games for free at games.easybranches.com

Guest Post Services www.easybranches.com/contribute